SCHEMBL5129129

SCHEMBL5129129

COc1ccccc1-c1cccc(Oc2cc(CC(=O)O)cc(OCC3CC3)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 9/20 0.46
PPARD Q03181 4/20 0.44
THRA P10827 1/20 0.44
THRB P10828 1/20 0.44
FABP1 P07148 1/20 0.43
ACACB O00763 2/20 0.42
ACACA Q13085 2/20 0.42
PPARA Q07869 1/20 0.42
CTSA P10619 1/20 0.41
PTGER4 P35408 2/20 0.41
PTGER1 P34995 1/20 0.41
PTGER3 P43115 1/20 0.41
PTGER2 P43116 1/20 0.41
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CCR8 P51685 1/20 0.40
FFAR4 Q5NUL3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5122669 0.88 FFAR1 (0.48) FFAR1PPARDTHRATHRBCTSA
SCHEMBL5129463 0.86 FFAR1 (0.47) FFAR1THRATHRBCTSAPTGER4
SCHEMBL5126065 0.86 FFAR1 (0.47) FFAR1THRATHRBFABP1CTSA
SCHEMBL5126743 0.86 FFAR1 (0.53) FFAR1PPARDTHRATHRBFABP1
SCHEMBL5129275 0.86 PPARD (0.55) FFAR1PPARDFABP1ACACBACACA
SCHEMBL5129383 0.85 THRA (0.45) FFAR1PPARDTHRATHRBFABP1
SCHEMBL14605874 0.83 FFAR1 (0.50) FFAR1PPARDTHRATHRBFABP1
SCHEMBL5126543 0.82 ACACA (0.44) FFAR1PPARDFABP1ACACBACACA
SCHEMBL5132056 0.81 ACACA (0.49) FFAR1PPARDFABP1ACACBACACA
SCHEMBL5131973 0.81 FFAR1 (0.46) FFAR1PPARDTHRATHRBFABP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249137-A1 PPAR active compounds PLEXXIKON INC 2008-10-09 US disclosed
US-20080249137-A1 PPAR active compounds PLEXXIKON INC 2008-10-09 US disclosed
US-20080249137-A1 PPAR active compounds PLEXXIKON INC 2008-10-09 US disclosed
WO-2007030567-A2 PPARACTIVE COMPOUNDS PLEXXIKON, INC. (US) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249137-A1 PPAR active compounds PPARG, PPARA, PPARD FFAR1 57/4885PPARD 3/4885THRA 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.